Arkolith/Insider Trading/ABUS/Form 4

Sofia Michael J.

Chief Scientific OfficerArbutus Biopharma Corp (ABUS) · full profile →Form 4 · filed Dec 3, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2021Sell(S)200K$5.09$1.0M1.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001447028-21-000068) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML